HER2 Support Group Forums - View Single Post - more on brain mets in her2+ metastatic breast cancer (prevention recommended)

julierene · 03-26-2006, 08:31 PM

(26.0%) developed brain metastases including 26.2% and 25.5% who did and did not receive trastuzumab (p = 0.93). Median time to brain relapse from the diagnosis of MBC was 10 months (range, 0 to 65 months). Detailed analysis of factors related to the risk of CNS metastases will be presented during the conference.

I just had a clear brain MRI. But I'm still worried!

Is this what 1 out of 4 have to look forward to in 10 months?

03-26-2006, 08:31 PM	#2
julierene Senior Member Join Date: Dec 2005 Location: Illinois Posts: 327	(26.0%) developed brain metastases including 26.2% and 25.5% who did and did not receive trastuzumab (p = 0.93). Median time to brain relapse from the diagnosis of MBC was 10 months (range, 0 to 65 months). Detailed analysis of factors related to the risk of CNS metastases will be presented during the conference. I just had a clear brain MRI. But I'm still worried! Is this what 1 out of 4 have to look forward to in 10 months? Last edited by julierene; 03-26-2006 at 08:45 PM..